Evaluation of Minimal Residual Disease (MRD) By Next Generation Sequencing (NGS) Is Highly Predictive of Progression Free Survival in the IFM/DFCI 2009 Trial
(1)
,
(1)
,
(2)
,
(3)
,
,
(4, 5)
,
(6)
,
(2)
,
(7)
,
(8)
,
(9)
,
,
,
(10)
,
(11)
,
,
,
(12)
,
(13)
,
(14, 15)
,
(16)
,
,
,
,
(5)
,
(17)
,
(18)
,
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
Herve Avet-Loiseau
- Function : Author
- PersonId : 948224
- ORCID : 0000-0002-3050-0140
Jill Corre
- Function : Author
- PersonId : 1186142
- ORCID : 0000-0003-1580-6106
Nelly Robillard
- Function : Author
Laurent Garderet
- Function : Author
- PersonId : 761986
- ORCID : 0000-0002-6138-8112
Lionel Karlin
- Function : Author
Frederique Orsini-Piocelle
- Function : Author
Bruno Royer
- Function : Author
Paul G. Richardson
- Function : Author
Kenneth C. Anderson
- Function : Author
Malek Faham
- Function : Author
Philippe Moreau
- Function : Author
- PersonId : 759214
- ORCID : 0000-0003-1780-8746
Nikhil C Munshi
- Function : Author
Abstract
57th Annual Meeting of the American-Society-of-Hematology Location: Orlando, FL Date: DEC 05-08, 2015